Wen Bu

2.1k total citations
32 papers, 1.2k citations indexed

About

Wen Bu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Wen Bu has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Oncology and 8 papers in Genetics. Recurrent topics in Wen Bu's work include Cancer Cells and Metastasis (12 papers), Virus-based gene therapy research (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Wen Bu is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Virus-based gene therapy research (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Wen Bu collaborates with scholars based in United States, China and Switzerland. Wen Bu's co-authors include Yi Li, Jeffrey M. Rosen, Bart O. Williams, Susan G. Hilsenbeck, Charlotta Lindvall, Zhimin Lu, Weiwei Yang, Lin Zhang, Mei Yee Koh and Paul J. Chiao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Wen Bu

32 papers receiving 1.1k citations

Peers

Wen Bu

ONCOL

IMMUN

GENET

Haineng Xu China

Harald J. Maier Germany

Véronique Gire France

Qiang Zou China

Oriol de Barrios Spain

Karine Belguise France

Teruaki Fujishita Japan

Regan M. Memmott United States

Anna Garuti Italy

Haineng Xu China

Wen Bu

560 ×0.8

346 ×0.6

ONCOL

220 ×0.7

238 ×1.3

IMMUN

54 ×0.4

GENET

Citations per year, relative to Wen Bu Wen Bu (= 1×) peers Haineng Xu

Countries citing papers authored by Wen Bu

Since Specialization

Citations

This map shows the geographic impact of Wen Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Bu more than expected).

Fields of papers citing papers by Wen Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Bu. The network helps show where Wen Bu may publish in the future.

Co-authorship network of co-authors of Wen Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Bu. A scholar is included among the top collaborators of Wen Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Bu. Wen Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bu, Wen & Yi Li. (2025). Rat Models of Breast Cancer. Advances in experimental medicine and biology. 1464. 123–148. 1 indexed citations

Dong, Xiaofei, et al.. (2024). A Survey of LLM-based Agents: Theories, Technologies, Applications and Suggestions. 407–413. 3 indexed citations

Bu, Wen & Yi Li. (2023). Advances in Immunocompetent Mouse and Rat Models. Cold Spring Harbor Perspectives in Medicine. 14(3). a041328–a041328. 9 indexed citations

Bu, Wen, Chad J. Creighton, Carolina Gutiérrez, et al.. (2023). Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice. Science Advances. 9(19). eade0059–eade0059. 11 indexed citations

Ku, Amy T., Adelaide I.J. Young, Ahmed Atef Ibrahim, et al.. (2022). Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models. Cancer Prevention Research. 16(2). 65–73. 4 indexed citations

Wang, Xuan, Zhongcheng Shi, Ji‐Eun Kim, et al.. (2022). High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array. Journal of Proteomics. 262. 104596–104596. 9 indexed citations

Bu, Wen & Yi Li. (2020). Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo. Journal of Mammary Gland Biology and Neoplasia. 25(4). 389–396. 12 indexed citations

Bu, Wen, Zhenyu Liu, Weiyu Jiang, et al.. (2018). Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes. Cancer Research. 79(1). 61–71. 31 indexed citations

Bu, Wen, Sarah Hein, S. Garcia, et al.. (2018). Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Research. 20(1). 42–42. 53 indexed citations

10.

Xu, Yixiang, Dong-Kee Lee, Zhen Feng, et al.. (2017). Breast tumor cell-specific knockout of Twist1 inhibits cancer cell plasticity, dissemination, and lung metastasis in mice. Proceedings of the National Academy of Sciences. 114(43). 11494–11499. 82 indexed citations

11.

Zheng, Ze‐Yi, Lin Tian, Wen Bu, et al.. (2015). Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. Cell Reports. 12(3). 511–524. 42 indexed citations

12.

Bu, Wen, Xiang Zhang, Hua Dai, Shixia Huang, & Yi Li. (2013). Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis. PLoS ONE. 8(11). e78720–e78720. 9 indexed citations

13.

Yang, Weiwei, Yan Xia, Yu Cao, et al.. (2012). EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis. Molecular Cell. 48(5). 771–784. 219 indexed citations

14.

Lv, Dandan, Ha-Jeong Kim, Robert A. Kurt, et al.. (2012). A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells. Cell Research. 23(3). 394–408. 101 indexed citations

15.

Bu, Wen, Jun Chen, Shixia Huang, et al.. (2011). Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene. 30(43). 4399–4409. 43 indexed citations

16.

Reddy, Jay P., Sirisha Peddibhotla, Wen Bu, et al.. (2010). Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proceedings of the National Academy of Sciences. 107(8). 3728–3733. 46 indexed citations

17.

Xia, Xue, Xian‐Jun Qu, Ying Yang, et al.. (2010). Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. Biochemical and Biophysical Research Communications. 403(3-4). 398–404. 88 indexed citations

18.

Bu, Wen, Xin Li, Michael J. Toneff, Lei Li, & Yi Li. (2009). Lentivirus Vectors for Stably Introducing Genes into Mammary Epithelial Cells in Vivo. Journal of Mammary Gland Biology and Neoplasia. 14(4). 401–404. 32 indexed citations

19.

Siwko, Stefan, Wen Bu, Carolina Gutiérrez, et al.. (2008). Lentivirus-Mediated Oncogene Introduction into Mammary Cells In Vivo Induces Tumors. Neoplasia. 10(7). 653–IN1. 35 indexed citations

20.

Grimm, Sandra L., Wen Bu, Mary A. Longley, et al.. (2006). Keratin 6 is not essential for mammary gland development. Breast Cancer Research. 8(3). R29–R29. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact